Buchumschlag

Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastomaIntensitätsmodulierte Protonentherapie, volumenmodulierte Arc-Therapie und dreidimensionale konformale Radiotherapie beim anaplastischen Astrozytom und Glioblastom

PurposeThe prognosis for high-grade glioma (HGG) patients is poor; thus, treatment-related side effects need to be minimized to conserve quality of life and functionality. Advanced techniques such as proton radiation therapy (PRT) and volumetric-modulated arc therapy (VMAT) may potentially further r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Adeberg, Sebastian (VerfasserIn) , Harrabi, Semi B. (VerfasserIn) , Bougatf, Nina (VerfasserIn) , Bernhardt, Denise (VerfasserIn) , Hörner-Rieber, Juliane (VerfasserIn) , Körber, Stefan A. (VerfasserIn) , Syed, Mustafa (VerfasserIn) , Sprave, Tetyana (VerfasserIn) , Mohr, Angela (VerfasserIn) , Abdollahi, Amir (VerfasserIn) , Haberer, Thomas (VerfasserIn) , Herfarth, Klaus (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Rieken, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 22 June 2016
In: Strahlentherapie und Onkologie
Year: 2016, Jahrgang: 192, Heft: 11, Pages: 770-779
ISSN:1439-099X
DOI:10.1007/s00066-016-1007-7
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00066-016-1007-7
Verlag, Volltext: https://link.springer.com/article/10.1007/s00066-016-1007-7
Volltext
Verfasserangaben:S. Adeberg, S.B. Harrabi, N. Bougatf, D. Bernhardt, J. Rieber, S.A. Koerber, M. Syed, T. Sprave, A. Mohr, A. Abdollahi, T. Haberer, S.E. Combs, K. Herfarth, J. Debus, S. Rieken
Beschreibung
Zusammenfassung:PurposeThe prognosis for high-grade glioma (HGG) patients is poor; thus, treatment-related side effects need to be minimized to conserve quality of life and functionality. Advanced techniques such as proton radiation therapy (PRT) and volumetric-modulated arc therapy (VMAT) may potentially further reduce the frequency and severity of radiogenic impairment.Materials and methodsWe retrospectively assessed 12 HGG patients who had undergone postoperative intensity-modulated proton therapy (IMPT). VMAT and 3D conformal radiotherapy (3D-CRT) plans were generated and optimized for comparison after contouring crucial neuronal structures important for neurogenesis and neurocognitive function. Integral dose (ID), homogeneity index (HI), and inhomogeneity coefficient (IC) were calculated from dose statistics. Toxicity data were evaluated.ResultsTarget volume coverage was comparable for all three modalities. Compared to 3D-CRT and VMAT, PRT showed statistically significant reductions (p < 0.05) in mean dose to whole brain (−20.2 %, −22.7 %); supratentorial (−14.2 %, −20,8 %) and infratentorial (−91.0 %, −77.0 %) regions; brainstem (−67.6 %, −28.1 %); pituitary gland (−52.9 %, −52.5 %); contralateral hippocampus (−98.9 %, −98.7 %); and contralateral subventricular zone (−62.7 %, −66.7 %, respectively). Fatigue (91.7 %), radiation dermatitis (75.0 %), focal alopecia (100.0 %), nausea (41.7 %), cephalgia (58.3 %), and transient cerebral edema (16.7 %) were the most common acute toxicities.ConclusionEssential dose reduction while maintaining equal target volume coverage was observed using PRT, particularly in contralaterally located critical neuronal structures, areas of neurogenesis, and structures of neurocognitive functions. These findings were supported by preliminary clinical results confirming the safety and feasibility of PRT in HGG.
Beschreibung:Gesehen am 29.11.2017
Beschreibung:Online Resource
ISSN:1439-099X
DOI:10.1007/s00066-016-1007-7

Ähnliche Einträge